A Double-Blind, Placebo-Controlled Study of RGH-188 (Cariprazine) in Bipolar Depression.
Phase of Trial: Phase II
Latest Information Update: 30 Aug 2010
At a glance
- Drugs Cariprazine (Primary)
- Indications Bipolar depression
- Focus Therapeutic Use
- Sponsors Forest Laboratories
- 30 Aug 2010 Preliminary top-line results have been reported in a Forest Laboratories media release.
- 30 Jul 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 30 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History